Simplifying CRISPR Therapeutic Manufacturing: Practical Solutions to Accelerate and Simplify Manufacturing, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how simplifying supply chain management can accelerate the advancement of CRISPR-based therapies, reduce risk and ultimately bring therapies to market faster. Attendees will gain insight into how to address supply chain challenges like vendor cycle times and slot alignment. The featured speakers will share practical strategies to reduce delays and improve efficiency across sgRNA, pDNA, mRNA, LNP and fill/finish workflows. The speakers will discuss how integration across development and manufacturing can strengthen regulatory submissions and commercial readiness.

TORONTO, Oct. 9, 2025 /PRNewswire/ -- The rise of CRISPR-based therapies has reshaped the biopharmaceutical landscape, offering unprecedented opportunities for innovation and platform advancement. Yet for many organizations, the road from early development to commercialization remains complex.

One of the most pressing challenges lies in the management of multiple CDMOs and timelines. Programs often depend on multiple vendors, requiring teams to manage cycle times across different providers, align scarce slot availability and mitigate shipment risks between facilities. Each of these factors can introduce costly delays, increase regulatory complexity and ultimately extend the time needed to bring new therapies to market.

This webinar will provide attendees with practical strategies to address these challenges head-on. By highlighting the consolidated capabilities in nucleic acid manufacturing — including sgRNA, pDNA, mRNA, LNP formulation and fill/finish — the featured speakers will explore how program leaders can simplify coordination, reduce risks and improve readiness for scale-up and commercialization.

Key topics will include:

• Understanding how an end-to-end workflow improves overall project timelines and simplifies supply chain management
• Strategies to ensure slot availability aligns across critical manufacturing steps
• Best practices for minimizing shipment risks and maintaining product integrity across geographies
• The benefits of an integrated approach that unifies expertise, facilities and technologies under one framework

This webinar is designed for pharma and biopharma professionals responsible for development strategy, outsourcing and manufacturing coordination. Attendees will leave with actionable insights on how to streamline CRISPR therapeutic manufacturing, optimize regulatory preparedness and strengthen commercial readiness — tools they can apply within their own organizations.

Register for this webinar to learn how simplifying supply chain management can accelerate the advancement of CRISPR-based therapies, reduce risk and ultimately bring therapies to market faster.

Join Jessica Madigan, Director Business Development, Nucleic Acid Modalities, BIOVECTRA; and Amanda Haas, Business Development Manager, Agilent Technologies, for the live webinar on Monday, October 27, 2025, at 2pm EDT (11am PDT).

For more information or to register for this event, visit Simplifying CRISPR Therapeutic Manufacturing: Practical Solutions to Accelerate and Simplify Manufacturing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit www.xtalks.com
For information about hosting a webinar, visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks